phate, and pyridoxamine 5'-phosphate were from Sigma (London) Chemical Co., Kingston-uponThames, Surrey KT2 7BH, U.K. m-Chloroperoxybenzoic acid was from Ralph N. Emanuel Ltd., Wembley, Middx., U.K. The casein hydrolysate was a vitamin-free, acid-hydrolysed preparation of casein, known as 'casamino acids', purchased from Difco Laboratories, Detroit, Mich., U.SA. Kloeckera apiculata (National Collection of Yeast Cultures no. 245) was obtained from The Brewing Industry Research Foundation, Nutfield, Redhill, Surrey, U.K. Crystallized bovine plasma albumin was from Armour Pharmaceutical Co., Eastbourne, Sussex, U.K. The basal medium for Kloeckera apiculata was the same as that described by BartonWright (1961) for the microbiological assay of the vitamin B-6 complex with Kloeckera bretis, now renamed K. apiculata (Lodder, 1971) .
Method
Measurement of radioactivity. Liquid samples (1, 10 or 100,u1) were placed in 5ml of liquid-scintillation mixture (100g of naphthalene, 5g of 2,5-diphenyloxazole made up to 1 litre in 1,4-dioxan), and counted to an error of 1 % or less in a Beckman LS 200B liquid-scintillation system. The efficiency of counting was 27.5 %.
-Measurement ofprotein. Protein was measured by the method of Lowry et al. (1951) bovine plasma albumin being used as the standard.
Microbiological measurement of vitanin B-6. Vitamin B-6 was measured microbiologically by the method of Barton-Wright (1961) .
Synthesis of 34hydroxy-2,4,5-trihydroxymethylpyridine hydrochloride. 3-Hydroxy-2,4,5-trihydroxymethylpyridine hydrochloride was prepared as described by Bedford et al. (1963) , with two modifications. In the oxidation of 3-acetoxy-4,5-di(acetoxymethyl)-2-methylpyridine (Scheme 1, compound I1).to its N-oxide (compound III) (V) Chemicalsynthesis of3-hydroxy-2.4,5-trihydroxymethylpyridine ( -) )from pyridoxine (I) (Il), 3-Acetoxy-4,5-di(acetoxymethyl)-2-methylpyridine; (III), 3-acetoxy-4,5-di(acetoxymethyl)-2-methylpyridine 1-oxide; (IV), 3-acetoxy-2,4,5-tri(acetoxymethyl)pyridine. Procedures (small numbers above arrows): 1, Pyridine/acetic acid (1:1, v/v), 3h, 100°C, free base released with Na2CO3; 2, m-chloroperoxybenzoic acid in CHC13; 3, heated under reflux for 2h with acetic anhydride; 4, heated under reflux for 45min with 4M-HCI. Abbreviation: Ac, acetyl.
acid. The final product was not recrystallized; it was purified by column chromatography on Dowex 50 (H+ form) with a concave gradient of0-6M-HCI.
Synthesis of [G-3H] 3-hydroxy-2,4,5-trihydroxymethylpyridine hydrochloride. The sequence of reactions used for the synthesis of unlabelled 3-hydroxy-2,4,5-trihydroxymethylpyridine hydrochloride, and shown in Scheme 1, were adapted to the micro-scale preparation of the 3H-labelled compound.
[G-3HjPyridoxine hydrochloride (1 mCi, 0.137mg) was purchased as a sterile ml aqueous solution. This was evaporated to dryness by placing the opened vial in an evacuated desiccator over P205 in the dark. By using ml quantities of a mixture of pyridine and acetic anhydride (1:1, v/v), the contents of the vial were washed into a graduated 25ml tube until the total volume was 5ml. The tube was fitted with a condenser, and the solution was heated for 3h at 100°C on a boiling-water bath. After standing overnight at room temperature (15-20°C), the pyridine and acetic anhydride were removed by rotary evaporation. Diethyl ether (lOml) and a few drops of water were added to the residual oil. Solid Na2CO3 was then added and triturated with a glass rod, in order to neutralize any remaining acetic anhydride or acetic acid, and to convert the product into its free base (compound II The product (compound III) was a trace of oil, which contained small crystals of the impurity pyridine N-oxide. This was heated under reflux for 2h with acetic anhydride (8ml) to form 3-acetoxy-2,-4,5-tri(acetoxymethyl)pyridine (compound IV). The acetic anhydride was removed by rotary evaporation and compound (IV) was hydrolysed to compound (V) by heating under reflux for 45min with 4M-HCI (lOml). Water and HCl were removed by rotary evaporation and the product was applied to a column (3cm x 20cm) of Dowex 50 (H+ form). A concave gradient of 0-6M-HCI (produced from 600ml of water and 500ml of 6M-HCI) was passed through the column, and lOml fractions were collected. Samples (lOuil) of each fraction were taken for the assay of 3H. The hydrochloride of 3-hydroxy-2,4,5-trihydroxymethylpyridine (compound V) was eluted at V. = 340OIl, in a total volume of 60ml.
3H-labelled by-products, which were eluted earlier, accounted for about half of the total 3H. The chief by-product, which was unidentified, and did 1976 Scheme 1.
REDUCTION OF 3-HYDROXY-2,4,5-TRIHYDROXYMETHYLPYRIDINE not support the growth of K. apiculata, was eluted at V. = 1lOml. In this system, pyridoxine is eluted at V. = 420ml; if it were present, it would be well separated from the product. Fractions containing the product were dried by rotary evaporation, and the product was stored in a desiccator under decreased pressure over KOH in the dark. The product was chromatographically homogeneous, and showed the same behaviour as authentic 3-hydroxy-2,4,5-trihydroxymethylpyridine hydrochloride in the following systems: (1) paper chromatography in butan-l-ol/acetic acid/water (4:1:1, by vol.); (2) column chromatography on Dowex 50 (H+ form) with 0-6M-HCI as described above; (3) column chromatography on Dowex 50 (H+ form) with a combined pH-concentration gradient of ammonium formate (Tiselius, 1972) . In each of these systems, 3-hydroxy-2,4,5-trihydroxymethylpyridine is well separated from pyridoxal, pyridoxine, pyridoxamine and their phosphates, with the exception that there is some overlap with pyridoxal on the second Dowex column. The i.r. spectrum of the product was identical with that of authentic 3-hydroxy-2,4,5-trihydroxymethylpyridine hydrochloride. The mass spectrum of the hydrochloride of compound (V) showed a mass ion peak at 185, as expected for the free base C8H1104N. The specific radioactivity of the product was 1.05 Ci/mmol, which indicates that 30% of the 3H of the original radioactive pyridoxine was labilized during the preparation. This is in accordance with the manufacturer's claim that about 70% of the 3H is located in position 6 of the pyridine ring. 3H atoms in any other position of the molecule would be more labile, especially undeLacid conditions, and they are presumably lost during the preparation.
Growth of culture. Growth was followed by measurement of the E"' of cell suspensions.
The relationship between E540 and dry cell weight was determined in separate experiments by the procedure of Meynell & Meynell (1970) . A loop of K. apiculata from a stock slope was suspended in sterile water (5ml). The cells were packed by centrifugation and resuspended in sterile water (5ml). This suspension was added to the basal medium (500ml), which was incubated overnight at 30°C with forced aeration. Growth under these conditions in the absence of exogenous vitamin B-6 resulted in a resting cell population equivalent to 10-20pg dry wt./ml. This slight growth is due to the contamination of the basal medium with vitamin B-6, equivalent to 20-40ng of pyridoxine/litre,.
Compounds under investigation for vitamin B-6 activity were then added to the stationary cell culture, and the E540 was measured at intervals of 10-15min.
Preparation of cell extracts of K. apiculata.
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Basal medium (1 litre), containing [G-3H] This column does not separate 3-hydroxy-2,4,5-trihydroxymethylpyridine and pyridoxal. The column fractions containing 3-hydroxy-2,4,5-trihydroxymethylpyridine and/or pyridoxal were combined and the total radioactivity was determined. To remove ammonium formate, the mixture was chromatographed on Dowex 1 (C1-form) as described above, and pyridoxal and 3-hydroxy-2,4,5-trihydroxymethylpyridine were collected in a volume of 20ml; this was dried by rotary evaporation and the residue was dissolved in 0.1 M-NaOH (5mi). Solid NaBH4 (100mg) was added gradually over a period of 2mm with stirring, to convert the pyridoxal into pyridoxine. The mixture was acidified to pH 3.4 with 2M-H2SO4 and the 3-hydroxy-2,4,5-trihydroxymethylpyridine and pyridoxine were separated on a column (0.9cmx40cm) of Dowex 50 (H+ form) by the method of Tiselius (1972) as described above. The ratio of 3-hydroxy-2,4,5-trihydroxymethylpyridine to pyridoxine determined by radioactivity from this separation was taken to represent the original ratio of 3-hydroxy-2,4,5-trihydroxymethylpyridine to pyridoxal.
Analysis of protein-bound vitamin B-6. Pyridoxine hydrochloride, pyridoxine 5'-phosphate, pyridoxal hydrochloride, pyridoxal 5'-phosphate, pyridoxamine dihydrochloride, and pyridoxamine 5'-phosphate (1mg of each) were added to the protein-bound vitamin B-6 fraction, followed by trichloroacetic acid to a final concentration of 5% (w/v). The precipitated protein was removed by centrifugation and the supematant was shaken with an equal volume of diethyl ether to extract the trichloroacetic acid. The aqueous layer was then adjusted to pH10 with NaOH solution and placed on a column (2.5cmx 8cm) of Dowex 1 (Cl-form). The analysis was then performed as described above for free vitamin B-6. Results and Discussion Growth ofK. apiculata at the expense of3-hydroxy-2,4,5-trihydroxymethylpyridine Under the conditions described, the maximum rate of growth of K. apiculata was supported by 0.02,umol of pyridoxine, pyridoxal or pyridoxamine/ litre. Higher concentrations of any form of vitamin B-6 caused no further increase in the growth rate, and lower concentrations supported slower growth rates. At this maximum growth rate, the time required for doubling the dry cell mass was 75min. At concentrations higher than 0.01251umol/litre, pyridoxine, pyridoxal and pyridoxamine also supported a dry-cell-mass doubling time of 75min for the first 4h after the start of growth, but slower rates were then observed.
The shortest time for the doubling of dry cell mass supported by 3-hydroxy-2,4,5-trihydroxymethylpyridine was 110min, with the compound at a concentration of0.2 mol/litre; higher concentrationscaused no further increase in growth rate. In the range 0.125-0.2pmol of 3-hydroxy-2,4,5-trihydroxymethylpyridine/litre the differences in growth rate became manifest about 4h after the start of growth.
In the microbiological assay of vitamin B-6 with K. apiculata, 8nmol of 3-hydroxy-2,4,5-trihydroxymethylpyridine/litre, or 0.8nmol of pyridoxine/ litre support growth to a dry cell mass of 84pg/ml. At higher concentrations pyridoxine supports growth even more efficiently so that 3.5nmol of pyridoxine/ litre supports growth to a final dry cell mass of 3741ug/ ml, and35 nmol of3-hydroxy-2,4,5-trihydroxymethylpyridine/litre supports growth to a final dry cell mass of 240gg/ml. In these growth studies, the lag period was always 75min and it showed no dependence on the nature or concentration of the added compound.
Nevertheless, 3-hydroxy-2,4,5-trihydroxymethylpyridine can completely satisfy the vitamin B-6 requirement ofK. apicudata. Cultures of this organism have been subcultured for more than a year in our laboratory on vitamin B-6,free media supplemented with 3-hydroxy-2,4,5-trihydroxymethylpyridine. On transfer to media containing pyridoxine they show the same rate of growth as cultures maintained on pyridoxine.
According to Lodder (1971) the cells ofK. apiculata are apiculate (lemnon-shaped), ovoid, or elongate, single, in pairs, or occasionally in groups of three or four; wide variations in cell size, i.e. (1 .4-5.3)gmx (2.6-12.2),um, are also encountered. Under the present growth conditions such wide variations in shape and size have not been observed. Normal bipolar budding occurred during growth at the expense ofpyridoxine, or 3-hydroxy-2,4,5-trihydroxymethylpyridine, and the fully grown, slightly apiculate cells measured (4.2-4.4)gm x (2.6-2.8)pm (grown on pyridoxine), and (4.0-4.2)pm x (2.2-2.4)pm (grown on 3-hydroxy-2,4,5-trihydroxymethylpyridine), as determined by electron microscopy.
Anualysis of vitamin B-6 compounds in cells of K.
apiculata Table 1 shows the concentrations of vitamin B-6 compounds in the cells of K. apiculata under different conditions of growth. The measurement of radioactivity and the microbiological determination of vitamin B-6 in the cell extract before the Sephadex chromatography showed that the specific radioactivity of the total vitamin B-6 was 70% of that claimed for the purchased pyridoxine. It appears therefore that 30 % of the 3H of the labelled pyridoxine became labilized when it was metabolized by K. apiculata, and when it was converted chemically into 3-hydroxy-2,4,5-trihydroxymethylpyridine. Probably the remaining 70% is located entirely in position 6 of the pyridine ring. Vol. 154 T. A. SCOTT AND C. PICTON quantity of vitamin B-6 was therefore calculated from total radioactivity of each column fraction, by using a specific radioactivity of 1.05 Ci/mmol. During growth with pyridoxine, all the known forms of vitamin B-6 are found in K. apiculata. The highest concentration is shown by pyridoxamine (20.4pmol/mg of protein) and the concentration of pyridoxine is relatively low (1.6pmol/mg of protein). The presence of 4-pyridoxic acid S'-phosphate may be an artefact, resulting from the photo-oxidation of pyridoxal 5'-phosphate (Reiber, 1972) . However, the constancy of its occurrence in the free vitamin B-6 fractionofcells grownwith pyridoxine, and its absence from all the other systems analysed, some of which contained relatively high concentrations of pyridoxal 5'-phosphate, suggest that it is a normal constituent of cells grown with pyridoxine. All the known forms of vitamin B-6 were also present in stationary cells grown with pyridoxine. The concentration of pyridoxamine 5'-phosphate, however, was markedly lower and it was detected only in the protein-bound vitamin B-6 fraction, whereas the concentration of pyridoxine was relatively high. Under these conditions, the extent of growth is still limited by the concentration of pyridoxine in the medium (starting concn. 6.7nmol/litre). Since the intracellular concentration ofpyridoxine in stationary cells (43.5 pmol/mg of protein) was as high as 90% of that (48.1 pmol/mg of protein) in growing cells, it is concluded that the intracellular concentration of vitamin B-6 was not in excess of that required for growth, and a small decrease in this concentration prevented further cell budding. On the other hand, the active coenzyme form of vitamin B-6 is pyridoxal 5'-phosphate, which showed a higher concentration in stationary cells than in growing cells. During and after growth with 3-hydroxy-2,4,5-trihydroxymethylpyridine, not all vitamin B-6 compounds were present in detectable quantities. In both stationary and growing cells, the predominant compound was 3-hydroxy-2,4,5-trihydroxymethylpyridine; thus the total concentration of true Vitamin B-6 compounds (11.4pmol/mg of protein in growing cells; 17.3 pmol/mg of protein in stationary cells) was lower, whereas the total concentration, including 3-hydroxy-2,4,5-trihydroxymethylpyridine, was higher than in cells grown with pyridoxine. In view of this relatively large accumulation of 3-hydroxy-2,4,5-trihydroxymethylpyridine in the cells, the restricted ability of K. apiculata to use 3-hydroxy-2,4,5-trihydroxymethylpyridine as a supplement for true vitamin B-6 is not due to a slow rate of penetration of this compound into the cell.
These results show that K. apiculata converts 3-hydroxy-2,4,5-trihydroxymethylpyridine into other known forms of vitamin B-6. The high intracellular concentration of 3-hydroxy-2,4,5-trihydroxymethylpyridine raises the question of whether this compound might also substitute for true vitamin B-6, in addition to supporting growth by conversion in vitamin B-6. In this case, the oxidation and phosphorylation of 3-hydroxy-2,4,5-trihydroxymethylpyridine would be expected to produce a derivative that could replace pyridoxal 5'-phosphate. There is no evidence for the production of any such compound from 3-hydroxy-2,A,5-trihydroxymethylpyridine.
Probably 3-hydroxy-2A,5-trihydroxymethylpyridine is first converted into pyridoxine by reduction of the 2'-hydroxymethyl group. The reduction ofan alcohol group to an alkyl group in living organisms is found in the reduction of ribonucleotides to deoxyribonucleotides (Reichard, 1967) ; the reduction of 5,10 thylenetetrahydrofolate(thedehydrationproduct of hydroxymethyltetrahydrofolate) to methyltetrahydrofolate (Cathou & Buchanan, 1963) ; and, if the keto tautomer of 3-hydroxy-2,4,5-trihydroxymethylpyridine is considered, a plausible mechanism would be that shown inmScheme 2, which is analogous to the-reduction of a hydroxy acid derivative in the synthesis of fatty acids (White et al., 1973) .
Since K. apiculata does not synthesize vitamin B-6 from simple precursors and it depends entirely on an external source of this vitamin, it is not possible to perform the necessary isotopic-tracer experiments, or to obtain mutants to test the possibility that 3-hydroxy-2,4,5-trihydroxymethylpyridine is a true biological precursor of vitamin B-6. For studies of this kind, it would be necessary to use organisms such as Saccharomyces marxianus (Pardini & Argoudelis, 1968) . Saccharomyces fragilis (Schroer & Frieden, 1973) , or E. coli (Dempsey, 1966) , which are known to synthesize vitamin B-6from simple precursors. 
